Corporate Brochure

Through nationally recognised processes, Bellberry supports research across clinical trials, health and medical research, medical device, digital health and AI, social science, evaluation and observational studies.

Find out more about our key services and who we work with in our Corporate Brochure

Share this article:

Other articles

A blog for the latest news and articles related to the ethical review of human research from Bellberry Limited.

View all articles
Jul 31, 2026

NAMs HREC Review Checklist

Bellberry and ASCEPT, the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists, are pleased to release the draft NAMs HREC Review…

Read More
Jul 31, 2026

NAMs Workshop 2 Summary Report

Melbourne, 24 October 2025 Bellberry and ASCEPT (Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists) are pleased to release the summary…

Read More
Jul 13, 2026

Reconciliation Action Plan

Bellberry’s Reflect Reconciliation Action Plan (RAP) was officially endorsed by Reconciliation Australia on 1 May 2026 and is now publicly available on…

Read More
Jun 1, 2026

Impact Report 2025

We are proud to release the Bellberry Impact Report for 2025. To download your copy of the report please click the button…

Read More
May 19, 2026

Clinical Trial Activity Report 2025

The Clinical Trial Activity Report (CTAR) presents a summary of Bellberry's ethics review activity across all Human Research Ethics Committees (HRECs) in…

Read More
May 19, 2026

NAMs Workshop 1 Summary Report

Melbourne, 30 November 2024 Bellberry and ASCEPT (Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists) are pleased to release the summary…

Read More